Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.
From the official U.S. FDA label for saccharomyces boulardii, the active ingredient registered with NAFDAC.
Temporarily relieves the pain of fungal infections.**
Temporarily relieves the pain of fungal infections.**
Consult a physician for use in children under 12 years of age. IF PREGNANT OR BREAST-FEEDING , ask a health care professional before use. KEEP OUT OF THE REACH OF CHILDREN. In case of overdose (or accidental ingestion) get medical help or contact a Poison Control Center right away. Do not use if TAMPER EVIDENT seal is broken or missing.
Add the expiry date on your pack for a full Trust Score.
Scharomyces Boulardi contains Saccharomyces boulardii (250 mcg), as tablet, according to its NAFDAC registration record.
Yes. Scharomyces Boulardi is listed on the NAFDAC register under registration number A4-100418, and its registration is active as of 27 October 2026.
No WHO falsified or substandard medical product alert currently matches Scharomyces Boulardi in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number A4-100418, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
Temporarily relieves the pain of fungal infections.** (Summarised from the official U.S. FDA label for saccharomyces boulardii. Always follow your doctor or pharmacist.)
Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.